Skip to content

A Clinical Study Investigating Balance Dysfunction in Older Adults with Sarcopenia Based on the Gut-Brain-Muscle Axis

A Clinical Study Investigating Balance Dysfunction in Older Adults with Sarcopenia Based on the Gut-Brain-Muscle Axis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123733
Enrollment
Unknown
Registered
2026-04-29
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

older adults with sarcopenia:none

Sponsors

Zhongda Hospital, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: Sarcopenia: 1. Age 50-85 years; 2. meet the AWGS 2025 diagnostic criteria for sarcopenia; 3. Able to walk without assistive devices; 4. Able to understand and cooperate with the trial and voluntarily sign the informed consent form. Inclusion criteria for healthy controls: 1. age 50-85 years; 2. Able to walk without assistive devices; 3. Able to understand and cooperate with the trial and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with hypertension whose blood pressure cannot be controlled (systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg after taking medication); Diabetic patients with poor glycemic control (glycated hemoglobin >11%); 2. Severe cardiac or psychiatric disease (e.g., schizophrenia), severe liver and kidney function disease (e.g., liver cirrhosis, history of kidney stones, renal failure or dialysis), severe organ failure, neuromuscular or skeletal system disease (e.g., osteoporosis, severe osteoarthritis); 3. Presence of severe vestibular dysfunction or foot deformity; 4. Severe speech, audio-visual impairment that prevents normal communication with the researcher, or dementia or obvious depression, unable to understand the content of the questionnaire or scale; 5. Contraindications to MRI, such as ferromagnetic implants such as pacemakers, claustrophobia, etc.; 6. Patients with acute infection or antibiotics within one month prior to screening; 7. Other clinical subjects who are participating in the evaluation that affects the results of this study.

Design outcomes

Primary

MeasureTime frame
COP sway area;

Secondary

MeasureTime frame
Berg;Plantar pressure;sEMG;fNIRS;fMRI;Functional Reach Test, FRT;

Countries

China

Contacts

Public ContactWan Ruihan

Zhongda Hospital, Southeast University, Nanjing, Jiangsu

wanruih@163.com+86 187 5124 2707

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026